Anti-neoplastic Agents Flashcards
Cancer (Malignant neoplasia) Defined (3)
Uncontrolled growth and spread of abnormal cells
Tumors may be benign or malignant (cancer)
In cancer, cell proliferation (cell renewal and replacement (becomes unbalanced)
Goal of cancer treatment (2)
- Total cell kill
2. To kill cancer without destroying normal cells
First order kinetics: Fractional Cell Kill (2)
Cancer drugs kill a fixed percentage (proportion) of tumor cells and not a fixed number of cells
This means that the same dose which decreases tumor burden from 10^6 to 10^3 cells will be needed to decrease the burden from 10^3 to 10^0 cells
Log-cell kill hypothesis (3)
Magnitude of a tumor cell kill is a logarithmic function
A dose of an effective drug will reduce the cancer cell load from trillion cells to billion cells: 3-log-kill
One of the reason for use of drug combination
Generation Time
Time to complete one cycle
Growth Fraction
% of cell which are actively dividing
2 Types of Drugs Against Cancer `
- Cell-cycle specific
2. Cell-cycle non specific
Cell-Cycle Specific (CCS) Drugs (2)
Acts on cell undergoing division
In general, CCS drugs are MOST effective in high growth fraction tumors
Cell-Cycle Non Specific Drugs (2)
Acts on cell during any phase
Useful in LOW growth fraction sold tumors as well as high growth fraction tumors
Cell Cycle: 1 - Non phase specific (5)
- Alkylating agents
- Nitrosourea
- Dacarbazine
- Cisplatin
- Antitumor antibiotics
Cell Cycle: 2. Phase specific (CCS) - a: G1 phase defined and drugs (2)
Synthesis of cells components needed for DNA synthesis
L-asparaginase
Mitomycin
Cell Cycle: 2. Phase specific (CCS) - b: S-phase (7)
Period of DNA synthesis
- Cytarabine
- 6-mercaptopurine (6MP)
- 6-thioguanine (6TG)
- Methotreaxate (MTX)
- Hydroxyurea
- Etoposide
Cell Cycle: 2. Phase specific (CCS) - c: G2 phase (2)
Preparation for mitosis
Bleomycin
Cell Cycle: 2. Phase specific (CCS) - d: M phase (4)
Mitosis
- Vinblastine
- Vincristin
- Paclitaxel
Cell Cycle: 1 - Non phase specific: Alkylating Agents (6)
- Cyclophosphamide
- Ifosfamide
- Mechrorethamine
- Melphalan
- Chlorambucil
- Busulphan
Cell Cycle: 1 - Non phase specific: Alkylating Agents - Cyclophosphamide Activation
Converted in liver to 4 hydroxyl CP to form 2 metabolites, where when they reach normal cells, get converted into active to 2 active metabolites: acrolein
Cell Cycle: 1 - Non phase specific: Alkylating Agents MOA (2)
Donate alkyl groups to guanine N7 of DNA –> making it non-functional DNA
Bifunctional alkylating agents can cause intrastrand linking and cross-linking
Cell Cycle: 1 - Non phase specific: Alkylating Agents MOA 2 (1)
Alkylation of guanine can result in miscoding through abnormal base pairing with thymine
Cell Cycle: 1 - Non phase specific: Alkylating Agents - a. Cyclophosphamide Adverse Effect (1) and Prevention (1)
Hemorrhagic cystitis
Prevent it by Mesna
Cell Cycle: 1 - Non phase specific: Alkylating Agents - b. Nitrosurea Drugs (2) and MOA
- Carmustine
- Lomustine
- Semustine
Crosses BBB
Cell Cycle: 1 - Non phase specific: Alkylating agents - c. Platinum Agents - Cisplatin Side effects (3) and Prevention (1)
- Renal toxicity
- Peripheral sensory neuropathy
- Ototoxicity
- Renal toxicity
- Prevention: Amifostine (cytoprotectant) for renal toxicity
Cell Cycle: 1 - Non phase specific: Alkylating agents - c. Platinum Agents - Carboplatin Side Effect (1)
Myelosuppression
Cell Cycle: 1 - Non phase specific: Alkylating agents - c. Platinum Agents - Oxaliplatin (1)
Peripheral sensory
Cell Cycle: 1 - Non phase specific: Alkylating agents - d. Others (3)
- Procarbazine
- Dacarbazine
- Altretamine
Cell Cycle: 1 - Non phase specific: Alkylating agents - d. Others - Procarbazine MOA
Depolymerizes DNA
Cell Cycle: 1 - Non phase specific: Alkylating agents - d. Others - Procarbazine Use
Hodgkin’s, NHL
Cell Cycle: 1 - Non phase specific: Alkylating agents - d. Others - Procarbazine Adverse Effects (1)
Increased risk of secondary cancers - acute leukemia
Cell Cycle: 1 - Non phase specific: Alkylating agents - e. Busulphan Use (1)
CML
Cell Cycle: 1 - Non phase specific: Alkylating agents - e. Busulphan Adverse effects (4)
- Skin pigmentation
- Acute lung injury
- Chronic interstitial fibrosis
- Alveolar hemorrhage (busulphan lung)
Cell Cycle: 1 - Non phase specific: Alkylating agents - e. Busulphan - Chlorambucil Use
CLL
Cell Cycle: 1 - Non phase specific: Alkylating agents - e. Busulphan - Chlorambucil Adverse Effects (4)
- Bone marrow suppression
- Anemia
- Neutropenia
- Thrombocytopenia